Login / Signup
Reply to: Intravenous immunoglobulin (Gamunex® 10%) is licensed for the treatment of severe acute exacerbations of myasthenia gravis.
Fiammetta Vanoli
Renato Mantegazza
Published in:
Expert opinion on pharmacotherapy (2023)
Keyphrases
</>
myasthenia gravis
chronic obstructive pulmonary disease
cystic fibrosis
combination therapy
low dose